(Q52890329)

9 May 2018

title

CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model. (English)

1 reference

9 May 2018

author name string

Tam Nguyen-Hoai

1

1 reference

9 May 2018

Gerd Baldenhofer

2

1 reference

9 May 2018

Mona Sayed Ahmed

3

1 reference

9 May 2018

Minh Pham-Duc

4

1 reference

9 May 2018

Margarete Gries

5

1 reference

9 May 2018

Martin Lipp

6

1 reference

9 May 2018

Bernd Dörken

7

1 reference

9 May 2018

Antonio Pezzutto

8

1 reference

9 May 2018

Jörg Westermann

9

1 reference

9 May 2018

publication date

1 February 2012

1 reference

9 May 2018

published in

Journal of Gene Medicine

1 reference

9 May 2018

volume

14

1 reference

9 May 2018

issue

2

1 reference

9 May 2018

page(s)

128-137

1 reference

9 May 2018

DNA vaccines: immunology, application, and optimization*

cites work

1 reference

Developing DNA vaccines that call to dendritic cells

21 January 2018

1 reference

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

Genetic adjuvants for DNA vaccines

21 January 2018

1 reference

Chemical adjuvants for plasmid DNA vaccines.

21 January 2018

1 reference

Clinical utilization of chemokines to combat cancer: the double-edged sword

21 January 2018

1 reference

Cancer immunotherapy with chemoattractant peptides.

21 January 2018

1 reference

Dendritic cell trafficking: more than just chemokines.

21 January 2018

1 reference

T cells and their partners: The chemokine dating agency.

21 January 2018

1 reference

Orchestrating the orchestrators: chemokines in control of T cell traffic

21 January 2018

1 reference

CCR7 and its ligands: balancing immunity and tolerance

21 January 2018

1 reference

Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors

21 January 2018

1 reference

CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo

21 January 2018

1 reference

Biologic and therapeutic role of HER2 in cancer

21 January 2018

1 reference

CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity

21 January 2018

1 reference

Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.

21 January 2018

1 reference

Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA.

21 January 2018

1 reference

Cellular immunity to the Her-2/neu protooncogene

21 January 2018

1 reference

Vaccination for treatment and prevention of cancer in animal models.

21 January 2018

1 reference

Breast cancer vaccines: a clinical reality or fairy tale?

21 January 2018

1 reference

HER-2/neu as a target for cancer vaccines

21 January 2018

1 reference

DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies

21 January 2018

1 reference

Protection against mammary tumor growth by vaccination with full-length, modified human ErbB-2 DNA.

21 January 2018

1 reference

The roles of FLT3 in hematopoiesis and leukemia

21 January 2018

1 reference

Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization

21 January 2018

1 reference

Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice

21 January 2018

1 reference

Paracrine cytokine adjuvants in cancer immunotherapy

21 January 2018

1 reference

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent

21 January 2018

1 reference

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy

21 January 2018

1 reference

Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

21 January 2018

1 reference

Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF.

21 January 2018

1 reference

Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands

21 January 2018

1 reference

Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1.

21 January 2018

1 reference

Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy

21 January 2018

1 reference

EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model

21 January 2018

1 reference

CCL19 reduces tumour burden in a model of advanced lung cancer

21 January 2018

1 reference

Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression

21 January 2018

1 reference

The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells

21 January 2018

1 reference

CCR7 is involved in the migration of neutrophils to lymph nodes

21 January 2018

1 reference

The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment

21 January 2018

1 reference

Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells

21 January 2018

1 reference

CCL19 induces rapid dendritic extension of murine dendritic cells

21 January 2018

1 reference

CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities

21 January 2018

1 reference

Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance

21 January 2018

1 reference

The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity

21 January 2018

1 reference

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JGM.1651

1 reference

9 May 2018

1 reference

9 May 2018